- Home
- YMAB vs ARQ Comparison
YMAB vs ARQ Comparison
Compare YMAB & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- ARQ
- Stock Information
- Founded
- YMAB 2015
- ARQ 1996
- Country
- YMAB United States
- ARQ United States
- Employees
- YMAB N/A
- ARQ N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- YMAB Health Care
- ARQ
- Exchange
- YMAB Nasdaq
- ARQ NYSE
- Market Cap
- YMAB 192.4M
- ARQ 155.3M
- IPO Year
- YMAB 2018
- ARQ N/A
- Fundamental
- Price
- YMAB $4.32
- ARQ $5.97
- Analyst Decision
- YMAB Buy
- ARQ Strong Buy
- Analyst Count
- YMAB 11
- ARQ 1
- Target Price
- YMAB $17.55
- ARQ $8.00
- AVG Volume (30 Days)
- YMAB 182.8K
- ARQ 208.5K
- Earning Date
- YMAB 08-11-2025
- ARQ 08-11-2025
- Dividend Yield
- YMAB N/A
- ARQ N/A
- EPS Growth
- YMAB N/A
- ARQ N/A
- EPS
- YMAB N/A
- ARQ N/A
- Revenue
- YMAB $88,658,000.00
- ARQ $114,466,000.00
- Revenue This Year
- YMAB N/A
- ARQ $11.92
- Revenue Next Year
- YMAB $15.15
- ARQ $31.32
- P/E Ratio
- YMAB N/A
- ARQ N/A
- Revenue Growth
- YMAB 4.92
- ARQ 14.33
- 52 Week Low
- YMAB $3.55
- ARQ $3.34
- 52 Week High
- YMAB $16.11
- ARQ $8.11
- Technical
- Relative Strength Index (RSI)
- YMAB 43.02
- ARQ 65.84
- Support Level
- YMAB $4.23
- ARQ $5.63
- Resistance Level
- YMAB $4.62
- ARQ $6.14
- Average True Range (ATR)
- YMAB 0.24
- ARQ 0.29
- MACD
- YMAB -0.03
- ARQ 0.02
- Stochastic Oscillator
- YMAB 14.04
- ARQ 73.10
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.